Volume 3 - Issue 4 - July/August 2006

Frank J. Criado, MD

It was the December issue 2004 of VDM when we last editorialized about the status of carotid artery stenting (CAS) in these pages. And quite a bit has happened since! Taking into account the continuing strength and impact of carotid interventional… | Read More

J. Thomas Grayston, MD, Lee Ann Campbell, PhD, John R. Crouse, III, MD, William R. Hiatt, MD

Clinical Trials Investigating the Utility of Antibiotics in Cardiovascular Disease Chlamydia pneumoniae in atherosclerotic lesions. When we became aware of the presence of Chlamydia pneumoniae (C. pneumoniae) in atherosclerotic lesions in 1991, we… | Read More

Gary M. Ansel, MD, Mitchell J. Silver, DO, Charles F. Botti Jr., MD

An aging population with an increasing prevalence of diabetes and metabolic syndrome is developing in the United States. | Read More

Christopher Chambers, MD and Luis Sanchez, MD

Introduction The treatment of abdominal aortic aneurysms (AAA) has changed significantly over the last several years since Parodi’s first description of an endoluminally-placed infrarenal aortic stent graft.1 The continued evolut | Read More

Jeroen Diks, MD and Willem Wisselink, MD, PhD

While endoscopic surgery has rapidly made headway among various specialties, vascular surgeons worldwide still seem uncomfortable surrendering to this minimally invasive technique. | Read More

Daniel Ihnat, MD, Gerlinda Tynan-Cuisiner, MD, Joseph L. Mills Sr., MD

Multiple large prospective randomized trials have compared the treatment of patients that have arteriosclerotic occlusive disease or diabetes with 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase inhibitors versus placebo. | Read More

Ashar Wadoodi, MD, Said Abisi, MD, MRCS, Kevin Burnand, MD

<b>History</b> | Read More

Zvonimir Krajcer, MD

<b>Q. In what clinical cases is CryoPlasty<sup>®</sup> Therapy a particularly effective treatment method?</b> | Read More

J. Thomas Grayston, MD, Lee Ann Campbell, PhD, John R. Crouse, III, MD, William R. Hiatt, MD

Clinical Trials Investigating the Utility of Antibiotics in Cardiovascular Disease Chlamydia pneumoniae in atherosclerotic lesions. When we became aware of the presence of Chlamydia pneumoniae (C. pneumoniae) in atherosclerotic lesions in 1991, we… | Read More